It was almost a decade ago when medical trauma changed the life of Peter Culpepper, CFO at Provectus Pharmaceuticals, and propelled him towards a goal he continues to pursue to this day: Find a cure for cancer.... (Continue reading)
We believe the results show that PV-10 can be a viable treatment for metastatic melanoma, and we are focusing our efforts on completing the 80 patient study, while also making plans for our next steps in development.... (Continue reading)
Does Provectus have a cure for Cancer?... (Continue reading)
Provectus Pharmaceuticals Inc. has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic drug for a broad spectrum of cancers, available for select cancer patients.... (Continue reading)
Dr. Craig Dees, PhD, Chairman and Chief Executive Officer of Provectus said, "The progress we are making in the clinical trials of PV-10 helps pave the way for its possible future as a safe...... (Continue reading)